Mesoblast Receives FDA Clearance for Phase 2 Trial of MPCs in Active RA Patients

News   May 16, 2013

 
Mesoblast Receives FDA Clearance for Phase 2 Trial of MPCs in Active RA Patients
 
 
 
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Comments | 0 ADD COMMENT